Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 55(1): 203-10, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21078932

RESUMO

We present the results of the first detailed study of the antiproliferative and ultrastructural effects of amiodarone on Trypanosoma cruzi, the causative agent of Chagas' disease. Moreover, we report the effects of this compound on the recovery of F-actin fibrils, connexin43, and contractility in T. cruzi-infected cardiac myocytes. Amiodarone is the most prescribed class III antiarrhythmic agent and is frequently used for the symptomatic treatment of Chagas' disease patients with cardiac compromise. In addition, recent studies identified its antifungal and antiprotozoal activities, which take place through Ca(2+) homeostasis disruption and ergosterol biosynthesis blockade. We tested different concentrations of amiodarone (2.5 to 10 µM) on infected primary cultures of heart muscle cells and observed a dose- and time-dependent effect on growth of the clinically relevant intracellular amastigote form of T. cruzi. Ultrastructural analyses revealed that amiodarone had a profound effect on intracellular amastigotes, including mitochondrial swelling and disorganization of reservosomes and the kinetoplast and a blockade of amastigote-trypomastigote differentiation. Amiodarone showed no toxic effects on host cells, which recovered their F-actin fibrillar organization, connexin43 distribution, and spontaneous contractility concomitant with the drug-induced eradication of the intracellular parasites. Amiodarone is, therefore, a promising compound for the development of new drugs against T. cruzi.


Assuntos
Amiodarona/farmacologia , Citoesqueleto/metabolismo , Junções Comunicantes/metabolismo , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/metabolismo , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Células Cultivadas , Imunofluorescência , Camundongos , Miócitos Cardíacos/parasitologia , Trypanosoma cruzi/patogenicidade
2.
Am J Pathol ; 167(4): 993-1003, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16192635

RESUMO

The cytokine transforming growth factor-beta (TGF-beta) plays various functions in the control of Trypanosoma cruzi infectivity and in the progression of Chagas' disease. When we immunostained T. cruzi-infected cardiomyocytes (after either in vivo or in vitro infections) for TGF-beta, we observed stronger immunoreactivity in parasites than in host cells. TGF-beta immunoreactivity evolved during parasite cycle progression, with intense staining in amastigotes versus very faint staining in trypomastigotes. TGF-beta was present on the surface of amastigotes, in the flagellar pocket, and in intraparasitic vesicles as revealed by electron microscopy. However, no ortholog TGF-beta gene could be identified in the genome of T. cruzi by in silico analysis or by extensive polymerase chain reaction and reverse transcriptase-polymerase chain reaction studies. Immunoreactive TGF-beta was most probably taken up by the parasite from the host cell cytoplasm because such an internalization process of biotinylated TGF-beta could be observed in axenic amastigotes in vitro. These observations represent the first example of a novel mechanism by which a primitive unicellular protozoan can use host cell TGF-beta to control its own intracellular life cycle.


Assuntos
Estágios do Ciclo de Vida , Miócitos Cardíacos/metabolismo , Fator de Crescimento Transformador beta/metabolismo , Trypanosoma cruzi/crescimento & desenvolvimento , Trypanosoma cruzi/parasitologia , Actinas/metabolismo , Animais , Células Cultivadas , Doença de Chagas/metabolismo , Embrião de Mamíferos , Embrião não Mamífero , Fluoresceína-5-Isotiocianato , Técnica Indireta de Fluorescência para Anticorpo , Corantes Fluorescentes , Imuno-Histoquímica , Indóis , Camundongos , Microscopia Confocal , Miócitos Cardíacos/parasitologia , Faloidina/metabolismo , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/metabolismo , Rodaminas , Fatores de Tempo , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta/imunologia , Trypanosoma cruzi/ultraestrutura
3.
Cell Biol Educ ; 3(2): 99-110, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15257338

RESUMO

The advent of genomics, proteomics, and microarray technology has brought much excitement to science, both in teaching and in learning. The public is eager to know about the processes of life. In the present context of the explosive growth of scientific information, a major challenge of modern cell biology is to popularize basic concepts of structures and functions of living cells, to introduce people to the scientific method, to stimulate inquiry, and to analyze and synthesize concepts and paradigms. In this essay we present our experience in mixing science and education in Brazil. For two decades we have developed activities for the science education of teachers and undergraduate students, using microscopy images generated by our work as cell biologists. We describe open-air outreach education activities, games, cell modeling, and other practical and innovative activities presented in public squares and favelas. Especially in developing countries, science education is important, since it may lead to an improvement in quality of life while advancing understanding of traditional scientific ideas. We show that teaching and research can be mutually beneficial rather than competing pursuits in advancing these goals.


Assuntos
Biologia/métodos , Fenômenos Fisiológicos Celulares , Microscopia/métodos , Modelos Biológicos , Animais
4.
Int J Antimicrob Agents ; 23(3): 273-85, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15164969

RESUMO

We present the results of the first detailed study of the molecular and cellular basis of the antiproliferative effects of the bisphosphonate risedronate (Ris) on Trypanosoma cruzi, the causative agent of Chagas' disease. Ris and related compounds, which block poly-isoprenoid biosynthesis at the level of farnesyl pyrophosphate synthase, are currently used for the treatment of bone resorption disorders, but also display selective activity against trypanosomatid and apicomplexan parasites. Ris induced a dose-dependent effect on growth of the extracellular epimastigote form of T. cruzi; complete growth arrest and cell lysis ensued at 150 microM. Growth inhibition was associated with depletion of the parasite's endogenous sterols, but complete growth arrest and loss of cell viability took place before full depletion of these compounds, suggesting that disappearance of other essential poly-isoprenoids is involved in its anti-parasitic action. Ris had a variety of effects on cellular ultrastructure, including mitochondrial swelling, disorganisation of other organelles, such as reservosomes and the kinetoplast, together with the appearance of autophagic vesicles and progressive vacuolization of the cytoplasm. Ris had selective antiproliferative effects against the clinically relevant amastigote form of T. cruzi, and at 100 microM, was able to prevent completely the development of T. cruzi infection of murine muscle heart or Vero cells, and to cure cultures which were already infected. Ris induced drastic ultrastructural alterations in the intracellular parasites and blocked amastigote to trypomastigote differentiation, with no biochemical or ultrastructural effects on the host cells, which fully recovered their normal structure and activity after treatment. Ris is, therefore, a promising lead compound for the development of new drugs against T. cruzi.


Assuntos
Alquil e Aril Transferases/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Ácido Etidrônico/análogos & derivados , Ácido Etidrônico/farmacologia , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Células Cultivadas , Doença de Chagas/prevenção & controle , Chlorocebus aethiops , Geraniltranstransferase , Camundongos , Microscopia Eletrônica , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/parasitologia , Miócitos Cardíacos/patologia , Ácido Risedrônico , Esteróis/metabolismo , Trypanosoma cruzi/crescimento & desenvolvimento , Trypanosoma cruzi/metabolismo , Trypanosoma cruzi/ultraestrutura , Células Vero
5.
Int J Antimicrob Agents ; 23(3): 286-90, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15164970

RESUMO

We report the results of a study on the activity of the farnesyl-pyrophosphate synthase inhibitor risedronate (Ris) in a murine model of acute Chagas' disease. This compound displays rapid, cytocidal activity in vitro against Trypanosoma cruzi, but its in vivo activity had not been investigated previously. A murine model of acute Chagas' disease was used, in which experimental animals were infected with 10(3) trypomastigotes and intravenous treatment was started 24 h post-infection. In this model, Ris, at doses as low as 1 mg/kg per day given for 7 days, induced > 90% reductions in parasitaemia and increased very significantly (P = 0.001) the survival of treated animals. Higher doses (up to 10 mg/kg per day) led to further reductions in parasitaemia and mortality, with no deleterious effects on weight gain and general physical condition of the treated animals. There was no relapse of parasitaemia after discontinuation of treatment, suggesting trypanocidal, rather than trypanostatic, activity. This interpretation was confirmed by the almost complete disappearance of amastigote nests in the hearts of treated animals. However, no parasitological cures were observed in infected animals that received the bisphosphonate, probably due to the short treatment period. Taken together, these results indicate that Ris could be a useful lead compound for the development of new drugs effective against Chagas' disease.


Assuntos
Doença de Chagas/tratamento farmacológico , Ácido Etidrônico/análogos & derivados , Ácido Etidrônico/farmacologia , Tripanossomicidas/farmacologia , Doença Aguda , Alquil e Aril Transferases/antagonistas & inibidores , Animais , Doença de Chagas/parasitologia , Doença de Chagas/patologia , Modelos Animais de Doenças , Inibidores Enzimáticos/farmacologia , Feminino , Geraniltranstransferase , Coração/parasitologia , Camundongos , Miocárdio/patologia , Parasitemia/tratamento farmacológico , Ácido Risedrônico
6.
Ciênc. cult. (Säo Paulo) ; 50(1): 45-51, Jan.-Feb. 1998. tab, ilus
Artigo em Inglês | LILACS | ID: lil-213001

RESUMO

The use of nonionic detergents such as Triton X-100 and X-114, is of immense value in biological and biochemical research. These detergents have found numerous applications in the analysis of membrane proteins, enzymes, glycoconjugates and in the study of cytoskeleton structure. The method offers an excellent resolution when used in coordination with immunological methods such as, immunoelectrophoresis, immunoprecipitation and western blot analysis.


Assuntos
Bioquímica , Biologia , Detergentes , Pesquisa
7.
Mem. Inst. Oswaldo Cruz ; 85(1): 95-9, jan.-mar. 1990. tab, ilus
Artigo em Inglês | LILACS | ID: lil-85175

RESUMO

Megazol (CL 64,855) a very effective drug in experimental infections by Trypanosoma cruzi, and also in in vitro assays with vertebrate forms of the parasite, had its parasite, had its activity upon macromolecule biosynthesis tested using tissue culture-derived amastigote forms. Megazol presented a drastic inhibition of [3H]-uridine incorporation, suggesting a selective activity upon protein synthesis. Comparing the three drugs, megazol was more potent than nifurtimox and benznidazole in inhibiting protein an DNA synthesis. Megazol showed a 91% of inhibition of [3H]-leucine incorporation whereas nifurtimox and benznidazole, 0% and 2%, respectively. These latter two drugs inhibited the incorporation of all the precursors tested at similar levels, but the concentration of benznidazole was always three times higher, suggesting different mechanisms of action or, more probably, a greater efficiency of the 5-nitrofuran derivate in relation to the 2-nitroimidazole. So, wes conclude that the mode of action of megazol is different from the ones of nifurtimox and benznidazole and that its primary effect is associated with an impairment of protein synthesis


Assuntos
Animais , Técnicas In Vitro , Nitroimidazóis/farmacologia , Proteínas/biossíntese , Tiadiazóis/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Benzimidazóis/farmacologia , Combinação de Medicamentos , Leucina/metabolismo , Nifurtimox/farmacologia
8.
Mem. Inst. Oswaldo Cruz ; 82(2): 209-18, Apr.-June 1987. tab, ilus
Artigo em Inglês | LILACS | ID: lil-59389

RESUMO

As açöes de megazol, nifurtimox, benznidazol e allopurinol sobre o T. cruzi foram investigadas, através de microscopia ótica e eletrônica, pela análise do efeito direto sobre formas amastigotas e tripomastigotas e do efeito sobre a interaçäo de cultura de célula muscular cardíaca com tripomastigotas sangüíneos. A proliferaçäo de amastigotas em meio Warren foi inibida de modo dose-dependente por megazol, nifurtimox e benznidazol. O tratamento de amastigotas (25-50 micronM/24h) e de tripomastigotas (25 micronM/24h) levou a várias alteraçöes ultraestruturais nos parasitas. Estas três drogas tiveram também um efeito potente no tratamento de culturas de células cardíacas infectadas, quando adicionadas desde o início da interaçäo ou após um ou três dias de infecçäo. Os parasitas interiorizados mostraram um padräo de alteraçöes ultraestruturais semelhante ao observado no tratamento direto de formas amastigotas. A cultura primária de célula muscular cardíaca mostrou ser um modelo adequado para o estudo de drogas sobre formas intracelulares de T. cruzi e o ensaio de proliferaçäo de amastigotas em meio axênico, indicado para uma triagem inicial de drogas. Estes parâmetros nos parecem muito confiáveis para uma investigaçäo sistemática do mecanismo de açäo de drogas


Assuntos
Animais , Alopurinol/farmacologia , Benzimidazóis/farmacologia , Técnicas In Vitro , Miocárdio/citologia , Nifurtimox/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Miocárdio/ultraestrutura , Trypanosoma cruzi/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...